AUTOSTEM – Development of closed, scalable and AUTOmated robotic systems for therapeutic STEM cell manufacturing: aseptic systems from “Donor-to-Patient”

EU Project / Project Start /

In Europe's aging society, the need for complex medical interventions is growing, but so are the associated costs and challenges. Stem cell-based therapies offer innovative and effective cures for chronic, limiting and degenerative diseases, but lack methods for efficient, high-quality and cost-effective stem cell production. The aim of the AUTOSTEM project is to develop methods for upscaling the production of stem cells. For this purpose, more efficient methods for the isolation of mesenchymal stem cells (MSC) as well as new cell media, which comply with the Good Manufacturing Practice (GMP) guidelines and do not require animal additives, will be developed. Furthermore, a production system is being developed that enables the fully automated production of stem cells.